Global Cardiopulmonary Bypass Accessory Equipment Market, By Product (Oxygenator, ECMO Machine, Pumps, Cannula, Temperature Monitors, Heat Exchanger, Filters, Tubing Clamps, Hemoconcentrators, System Panel, Sensor and Accessories, Cardioplegia Control, Reservoir, Bubble Detector, Electronic Gas Blender, Electrical Venous Occluder, Venous Line Clamp and Accessories), Operation (Manually Operated, Electrically Operated and Battery Operated), Application (Cardiac Surgery, Cardiac Surgery Oxygenators, Acute Respiratory Failure Treatment, Lung Cancer, Transplant Operation and Others), Age (Adult, Geriatric and Pediatric), Modality (Standalone and Portable), End User (Hospitals, Cardiac Centers, Research and Academic Institutions, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Retail Sales) – Industry Trends and Forecast to 2031.
Cardiopulmonary Bypass Accessory Equipment Market Analysis and Size
The cardiopulmonary bypass accessory equipment market encompasses a range of essential tools for cardiac surgery, including cardiac surgery oxygenators. It also includes equipment for treating acute respiratory failure, addressing lung cancer, and facilitating transplant operations. These accessories play a critical role in supporting various medical procedures aimed at addressing cardiac and respiratory conditions, as well as advancing treatment options for lung-related illnesses and transplant surgeries.
Data Bridge Market Research analyses that the global cardiopulmonary bypass accessory equipment market, which was USD 15.93 billion in 2023, is expected to reach USD 25.01 billion by 2031, at a CAGR of 5.8% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Oxygenator, ECMO Machine, Pumps, Cannula, Temperature Monitors, Heat Exchanger, Filters, Tubing Clamps, Hemoconcentrators, System Panel, Sensor and Accessories, Cardioplegia Control, Reservoir, Bubble Detector, Electronic Gas Blender, Electrical Venous Occluder, Venous Line Clamp and Accessories), Operation (Manually Operated, Electrically Operated and Battery Operated), Application (Cardiac Surgery, Cardiac Surgery Oxygenators, Acute Respiratory Failure Treatment, Lung Cancer, Transplant Operation and Others), Age (Adult, Geriatric and Pediatric), Modality (Standalone and Portable), End User (Hospitals, Cardiac Centers, Research and Academic Institutions, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Third Party Distributor and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Medtronic (U.S.), LivaNova PLC (U.K.), Braile Biomedica (Brazil), MERA (Germany), Technowood International Pte. Ltd. (Singapore), Narang Medical Limited (India), EUROSETS (Italy), Teleflex Incorporated (U.S.), Getinge AB (Sweden), Terumo Corporation (Japan), Surge Cardiovascular (U.S.), Abbott (U.S.), Edwards Lifesciences Corporation (U.S.), SCHNELL MEDICAL CORP. (Japan), NIPRO (Japan), XENIOS AG (Germany), Advin Health Care (India), Boston Scientific Corporation (U.S.), APC Cardiovascular Ltd (U.K.), MicroPort Scientific Corporation (China), Alung Technologies, Inc. (U.S.), Berlin Heart (Germany), Jarvik Heart, Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Cardiopulmonary bypass accessory equipment refers to devices utilized during cardiac surgery to support circulation and oxygenation of blood outside the body. These include components such as oxygenators, tubing sets, filters, and temperature control devices, facilitating the diversion of blood from the heart and lungs for surgical procedures while maintaining vital physiological functions.
Global Cardiopulmonary Bypass Accessory Equipment Market Dynamics
Drivers
- Technological Innovations in Bypass Equipment Design
Advancements such as miniaturization, biocompatibility enhancements, and improved material durability enhance the safety and efficacy of bypass procedures. Novel features such as integrated monitoring systems, remote connectivity offer greater control, and real-time feedback during surgeries, improving patient outcomes. These innovations attract healthcare providers seeking state-of-the-art solutions for cardiac interventions, thereby fueling market growth driven by the constant quest for improved performance and patient care.
- Growing Geriatric Population Requiring Cardiac Interventions
With age, the incidence of cardiovascular diseases rises, necessitating surgical interventions such as coronary artery bypass grafting. As the elderly population expands globally, the demand for cardiac surgeries and associated bypass equipment increases. This demographic trend underscores the significance of bypass accessory equipment in addressing age-related cardiac conditions, thus serving as a significant driver for market growth in the healthcare sector.
Opportunities
- Integration of Artificial Intelligence for Real-Time Monitoring
Incorporating artificial intelligence (AI) into cardiopulmonary bypass accessory equipment enables real-time monitoring of patient vital signs and system performance, enhancing safety and efficiency during surgeries. AI algorithms can analyze complex data streams, detect abnormalities, and provide timely alerts to medical personnel, facilitating proactive interventions. This integration presents an opportunity to revolutionize patient care by improving surgical outcomes, reducing complications, and optimizing resource utilization. It also positions manufacturers to differentiate their products and meet the evolving demands of healthcare providers for advanced monitoring solutions.
- Customization of Equipment for Specialized Surgical Procedures
Customizing cardiopulmonary bypass accessory equipment for specialized surgical procedures enables tailored solutions to meet the unique needs of patients and surgeons. By offering equipment that caters to specific surgical requirements, manufacturers can enhance surgical precision, efficiency, and patient outcomes. This approach opens opportunities to collaborate closely with healthcare providers, develop innovative solutions for niche applications, and establish a competitive edge in the market.
Restraints/Challenges
- High Cost Associated with Advanced Equipment Development
Manufacturers encounter barriers in research and development due to the substantial investment required. This limits innovation and delays the introduction of new technologies. Additionally, high development costs translate to higher prices for consumers, potentially reducing demand. The market may experience slower growth rates as companies struggle to balance investment in innovation with affordability for customers, impacting competitiveness and market penetration.
- Limited Access to Specialized Training for Equipment Operation
Limited access to specialized training for equipment operation poses a challenge in the cardiopulmonary bypass accessory equipment market. Healthcare professionals require comprehensive training to safely and effectively operate these complex devices. Without adequate training programs, healthcare facilities may hesitate to invest in cardiopulmonary bypass accessory equipment, leading to reduced demand. Additionally, inadequate training may increase the risk of improper device usage, compromising patient safety and outcomes.
This global cardiopulmonary bypass accessory equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cardiopulmonary bypass accessory equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In April 2022, LivaNova commenced the targeted commercial release of Essenz, a Patient Monitor for cardiopulmonary bypass procedures. This innovative system employs a patient-tailored approach to enhance clinical efficiency and patient care quality during cardiopulmonary bypass procedures, marking a significant advancement in the cardiopulmonary bypass accessory equipment market
- In February 2022, Getinge completed the acquisition of Talis Clinical LLC, a prominent US-based provider of cloud-based software solutions for high-acuity care. Talis Clinical's offerings, tailored for perioperative, labor and delivery, and critical care support, including ECMO therapy, strengthen Getinge's portfolio and enhance its position in the cardiopulmonary bypass accessory equipment market
- In June 2021, ABIOMED obtained FDA premarket approval for Impella RP with Smart Assist, a breakthrough in treating acute heart failure. This approval is poised to boost ABIOMED's revenue by expanding its presence and offering advanced solutions in the cardiopulmonary bypass accessory equipment market
- In January 2021, Eurosets launched its ECMOlife system globally, excluding the USA, for Extracorporeal Life Support (ECLS). This expansion of Eurosets' portfolio offers temporary patient support in various therapeutic areas, including Extracorporeal Membrane Oxygenation (ECMO) and Mechanical Circulatory Support (MCS), enriching options in the cardiopulmonary bypass accessory equipment market
Global Cardiopulmonary Bypass Accessory Equipment Market Scope
The global cardiopulmonary bypass accessory equipment market is segmented on the basis of product, operation, application, age, modality, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Oxygenator
- ECMO Machine
- Pumps
- Cannula
- Temperature Monitors
- Heat Exchanger
- Filters
- Tubing Clamps
- Hemoconcentrators
- System Panel
- Sensor and Accessories
- Cardioplegia Control
- Reservoir
- Bubble Detector
- Electronic Gas Blender
- Electrical Venous Occluder
- Venous Line Clamp
- Accessories
Operation
- Manually Operated
- Electrically Operated
- Battery Operated
Application
- Cardiac Surgery
- Cardiac Surgery Oxygenators
- Acute Respiratory Failure Treatment
- Lung Cancer
- Transplant Operation
- Others
Age
- Adult
- Geriatric
- Pediatric
Modality
- Standalone
- Portable
End User
- Hospitals
- Cardiac Centers
- Research and Academic Institutions
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tender
- Third Party Distributor
- Retail Sales
Global Cardiopulmonary Bypass Accessory Equipment Market Regional Analysis/Insights
The global cardiopulmonary bypass accessory equipment market is analysed and market size insights and trends are provided by product, operation, application, age, modality, end user and distribution channel as referenced above.
The countries covered in the global cardiopulmonary bypass accessory equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
In Europe, Germany is expected to lead the cardiopulmonary bypass accessory equipment market due to increasing opportunities, rising cases of cardiovascular diseases, and a growing elderly population.
North America is expected to lead the market due to its significant consumer base, rising cardiovascular disease incidence, and technological advancements. Within North America, the U.S. is expected to dominate, driven by its substantial consumer market, high GDP, increasing cardiovascular disease prevalence, and the presence of numerous market players.
In the Asia-Pacific region, China is expected to dominate the market, driven by heightened awareness of treatment options and widespread adoption of advanced technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The global cardiopulmonary bypass accessory equipment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cardiopulmonary bypass accessory equipment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global cardiopulmonary bypass accessory equipment market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Cardiopulmonary Bypass Accessory Equipment Market Share Analysis
The global cardiopulmonary bypass accessory equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cardiopulmonary bypass accessory equipment market.
Some of the major players operating in the global cardiopulmonary bypass accessory equipment market are:
- Medtronic (U.S.)
- LivaNova PLC (U.K.)
- Braile Biomedica (Brazil)
- MERA (Germany)
- Technowood International Pte. Ltd. (Singapore)
- Narang Medical Limited (India)
- EUROSETS (Italy)
- Teleflex Incorporated (U.S.)
- Getinge AB (Sweden)
- Terumo Corporation (Japan)
- Surge Cardiovascular (U.S.)
- Abbott (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- SCHNELL MEDICAL CORP. (Japan)
- NIPRO (Japan)
- XENIOS AG (Germany)
- Advin Health Care (India)
- Boston Scientific Corporation (U.S.)
- APC Cardiovascular Ltd (U.K.)
- MicroPort Scientific Corporation (China)
- Alung Technologies, Inc. (U.S.)
- Berlin Heart (Germany)
- Jarvik Heart, Inc. (U.S.)
- ABIOMED (U.S.)
SKU-